PlaqueTec

PlaqueTec Focuses on Developing Biomarker Systems to Facilitate Drug Development Targeting Inflammatory Processes in the Progression of Coronary Artery Disease. The Company’s Technology Assists in Collecting Bio-Data Related to Heart Disease from Coronary Arteries, Enabling Cardiologists to Obtain Further Information from Patients’ Coronary Arteries and Provide More Effective Treatments for Patients Affected by the Disease.